Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping Xia

Showing results (541-550 of 554) with videos related to

Pageof 56
Sort By:
Emerging Infectious Diseases|October 21, 2015
Ebola Virus Outbreak Investigation, Sierra Leone, September 28-November 11, 2014Hui-Jun Lu, Jun Qian, David Kargbo, et al.
Practical Radiation Oncology|January 22, 2026
Dose-Volume Histogram Compendium of Dose Constraints for Treatment Planning: An ASTRO Consensus PaperLindsay L Puckett, Smith Apisarnthanarax, Leslie K Ballas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2022
<sup>18</sup>F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002Rathan M Subramaniam, Lyudmila DeMora, Min Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2019
Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in MelanomaRui-Yan Wu, Peng-Fei Kong, Liang-Ping Xia, et al.
Oral Oncology|June 3, 2020
Association of body composition with survival and inflammatory responses in patients with non-metastatic nasopharyngeal cancerWen-Zhuo He, Chang Jiang, Li-Li Liu, et al.
Nature Microbiology|September 6, 2016
Intra-host dynamics of Ebola virus during 2014Ming Ni, Chen Chen, Jun Qian, et al.
The Lancet. Oncology|January 21, 2023
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trialEric J Sherman, Jonathan Harris, Keith C Bible, et al.
Cancers|June 19, 2024
Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based ApproachDu Wang, Huaizhi Geng, Vinai Gondi, et al.
BMC Medicine|March 17, 2023
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trialLin-Quan Tang, Xiao-Yun Li, Zhi-Ming Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)Sue S Yom, Pedro Torres-Saavedra, Jimmy J Caudell, et al.
Pageof 56

Showing results (541-550 of 554) with videos related to

Sort By:
Pageof 56
Emerging Infectious Diseases|October 21, 2015
Ebola Virus Outbreak Investigation, Sierra Leone, September 28-November 11, 2014Hui-Jun Lu, Jun Qian, David Kargbo, et al.
Practical Radiation Oncology|January 22, 2026
Dose-Volume Histogram Compendium of Dose Constraints for Treatment Planning: An ASTRO Consensus PaperLindsay L Puckett, Smith Apisarnthanarax, Leslie K Ballas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2022
<sup>18</sup>F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002Rathan M Subramaniam, Lyudmila DeMora, Min Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2019
Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in MelanomaRui-Yan Wu, Peng-Fei Kong, Liang-Ping Xia, et al.
Oral Oncology|June 3, 2020
Association of body composition with survival and inflammatory responses in patients with non-metastatic nasopharyngeal cancerWen-Zhuo He, Chang Jiang, Li-Li Liu, et al.
Nature Microbiology|September 6, 2016
Intra-host dynamics of Ebola virus during 2014Ming Ni, Chen Chen, Jun Qian, et al.
The Lancet. Oncology|January 21, 2023
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trialEric J Sherman, Jonathan Harris, Keith C Bible, et al.
Cancers|June 19, 2024
Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based ApproachDu Wang, Huaizhi Geng, Vinai Gondi, et al.
BMC Medicine|March 17, 2023
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trialLin-Quan Tang, Xiao-Yun Li, Zhi-Ming Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)Sue S Yom, Pedro Torres-Saavedra, Jimmy J Caudell, et al.
Pageof 56